GENENTA SCIENCE(SP.ADR)/1 - Asset Resilience Ratio

Latest as of December 2025: 70.94%

GENENTA SCIENCE(SP.ADR)/1 (K5F) has an Asset Resilience Ratio of 70.94% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€22.62 Million

≈ $26.45 Million USD Cash + Short-term Investments

Total Assets

€31.89 Million

≈ $37.28 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how GENENTA SCIENCE(SP.ADR)/1's Asset Resilience Ratio has changed over time. See GENENTA SCIENCE(SP.ADR)/1 (K5F) flexibility index to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down GENENTA SCIENCE(SP.ADR)/1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see K5F stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€22.62 Million	70.94%
Total Liquid Assets	€22.62 Million	70.94%

Asset Resilience Insights

Very High Liquidity: GENENTA SCIENCE(SP.ADR)/1 maintains exceptional liquid asset reserves at 70.94% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

GENENTA SCIENCE(SP.ADR)/1 Industry Peers by Asset Resilience Ratio

Compare GENENTA SCIENCE(SP.ADR)/1's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Amicus Therapeutics Inc NASDAQ:FOLD	Biotechnology	8.37%
Sk Biopharmaceuticals Co Ltd KO:326030	Biotechnology	0.14%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%

Annual Asset Resilience Ratio for GENENTA SCIENCE(SP.ADR)/1 (2021–2025)

The table below shows the annual Asset Resilience Ratio data for GENENTA SCIENCE(SP.ADR)/1.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	70.94%	€22.62 Million ≈ $26.45 Million	€31.89 Million ≈ $37.28 Million	+16.44pp
2024-12-31	54.49%	€8.08 Million ≈ $9.44 Million	€14.82 Million ≈ $17.33 Million	-13.01pp
2023-12-31	67.50%	€15.08 Million ≈ $17.64 Million	€22.35 Million ≈ $26.13 Million	--
2022-12-31	0.00%	€0.00 ≈ $0.00	€33.44 Million ≈ $39.09 Million	--
2021-12-31	0.00%	€0.00 ≈ $0.00	€40.03 Million ≈ $46.80 Million	--

pp = percentage points

About GENENTA SCIENCE(SP.ADR)/1

F:K5F Germany Biotechnology

Market Cap

$14.25 Million

€12.18 Million EUR

Market Cap Rank

#26148 Global

#2253 in Germany

Share Price

€0.52

Change (1 day)

+0.00%

52-Week Range

€0.47 - €3.68

All Time High

€10.50